BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 3244302)

  • 1. [Long-term results of surgical therapy of prolactin-secreting hypophysis macroadenomas].
    Candrino R; Tosoni M
    Medicina (Firenze); 1988; 8(4):434-6. PubMed ID: 3244302
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment of hypophyseal prolactin-secreting macroadenomas].
    Candrina R; Tosoni M
    Recenti Prog Med; 1989 Sep; 80(9):471-3. PubMed ID: 2595078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endocrinological outcome following first time transsphenoidal surgery for GH-, ACTH-, and PRL-secreting pituitary adenomas.
    Kristof RA; Schramm J; Redel L; Neuloh G; Wichers M; Klingmüller D
    Acta Neurochir (Wien); 2002 Jun; 144(6):555-61; discussion 561. PubMed ID: 12111488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Long-term surgical results of microprolactinomas].
    Hirohata T; Uozumi T; Mukada K; Arita K; Kurisu K; Yano T; Takechi A; Onda J
    No Shinkei Geka; 1991 Oct; 19(10):951-6. PubMed ID: 1944780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiosurgery for pituitary adenomas.
    Brada M; Ajithkumar TV; Minniti G
    Clin Endocrinol (Oxf); 2004 Nov; 61(5):531-43. PubMed ID: 15521954
    [No Abstract]   [Full Text] [Related]  

  • 6. [Efficacy of total removal or subtotal removal combined gamma knife radiation on giant pituitary adenoma: a report of 160 cases].
    Xiao QH; Huang SQ; Mao BY; Li GP; Ju Y
    Ai Zheng; 2007 Jul; 26(7):742-7. PubMed ID: 17626751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The treatment of prolactinoma].
    Serri O; Somma M; Beauregard H; Rasio E; Comtois R; Aris-Jilwan N; Boucher A; Hardy J
    Union Med Can; 1993; 122(6):496-9. PubMed ID: 7905686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic factors in prolactin pituitary tumors: clinical, histological, and molecular data from a series of 94 patients with a long postoperative follow-up.
    Raverot G; Wierinckx A; Dantony E; Auger C; Chapas G; Villeneuve L; Brue T; Figarella-Branger D; Roy P; Jouanneau E; Jan M; Lachuer J; Trouillas J;
    J Clin Endocrinol Metab; 2010 Apr; 95(4):1708-16. PubMed ID: 20164287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prolactin secreting pituitary carcinoma.
    Petterson T; MacFarlane IA; MacKenzie JM; Shaw MD
    J Neurol Neurosurg Psychiatry; 1992 Dec; 55(12):1205-6. PubMed ID: 1479402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and histological correlations in prolactinomas, with special reference to bromocriptine resistance.
    Delgrange E; Sassolas G; Perrin G; Jan M; Trouillas J
    Acta Neurochir (Wien); 2005 Jul; 147(7):751-7; discussion 757-8. PubMed ID: 15971099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biochemical remission and recurrence rate of secreting pituitary adenomas after transsphenoidal adenomectomy: long-term endocrinologic follow-up results.
    Santoro A; Minniti G; Ruggeri A; Esposito V; Jaffrain-Rea ML; Delfini R
    Surg Neurol; 2007 Nov; 68(5):513-8; discussion 518. PubMed ID: 17961741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Indications for surgery in the treatment of hyperprolactinemia.
    Zacur HA
    J Reprod Med; 1999 Dec; 44(12 Suppl):1127-31. PubMed ID: 10649823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of the Leksell gamma knife in the treatment of prolactinoma patients.
    Jezková J; Hána V; Krsek M; Weiss V; Vladyka V; Liscák R; Vymazal J; Pecen L; Marek J
    Clin Endocrinol (Oxf); 2009 May; 70(5):732-41. PubMed ID: 18710463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Transsphenoidal approach to prolactinomas].
    López-Arbolay O; Morales-Sabina O; González-González JL; Valdés-Lorenzo N
    Neurocirugia (Astur); 2006 Jun; 17(3):226-31. PubMed ID: 16855780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endocrine response after gamma knife-based stereotactic radiosurgery for secretory pituitary adenoma.
    Tinnel BA; Henderson MA; Witt TC; Fakiris AJ; Worth RM; Des Rosiers PM; Edmondson JW; Timmerman RD; Lo SS
    Stereotact Funct Neurosurg; 2008; 86(5):292-6. PubMed ID: 18758206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term follow-up of patients with pituitary macroadenomas after postoperative radiation therapy: analysis of tumor control and functional outcome.
    Langsenlehner T; Stiegler C; Quehenberger F; Feigl GC; Jakse G; Mokry M; Langsenlehner U; Kapp KS; Mayer R
    Strahlenther Onkol; 2007 May; 183(5):241-7. PubMed ID: 17497095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endoscopic transsphenoidal treatment in recurrent and residual pituitary adenomas--first experience.
    Rudnik A; Zawadzki T; Gałuszka-Ignasiak B; Bazowski P; Duda I; Wojtacha M; Rudnik AI; Krawczyk I
    Minim Invasive Neurosurg; 2006 Feb; 49(1):10-4. PubMed ID: 16547875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surgery for prolactinomas.
    Razzaq AA; Jooma R; Ahmed S
    J Pak Med Assoc; 2006 Apr; 56(4):181-3. PubMed ID: 16711341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microprolactinomas in males treated by transsphenoidal surgery.
    Wolfsberger S; Czech T; Vierhapper H; Benavente R; Knosp E
    Acta Neurochir (Wien); 2003 Nov; 145(11):935-40; discussion 940-1. PubMed ID: 14628197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Do the limits of serum prolactin in disconnection hyperprolactinaemia need re-definition? A study of 226 patients with histologically verified non-functioning pituitary macroadenoma.
    Karavitaki N; Thanabalasingham G; Shore HC; Trifanescu R; Ansorge O; Meston N; Turner HE; Wass JA
    Clin Endocrinol (Oxf); 2006 Oct; 65(4):524-9. PubMed ID: 16984247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.